Antimicrobial Stewardship Program: Time to be Focused in Speciality Settings of Leprosy Institute and Related Health Care Setup-Reference-Cited by-同舟云学术

Antimicrobial Stewardship Program: Time to be Focused in Speciality Settings of Leprosy Institute and Related Health Care Setup

Published:2024-08 Issue:2 Volume:19 Page:90-94
ISSN:2772-4344
Container-title:Recent Advances in Anti-Infective Drug Discovery
language:en
Short-container-title:RAAIDD

Author:

Thangaraju Pugazhenthan¹,Velmurugan Hemasri¹^ORCID,Venkatesan Sajitha²

Affiliation:

1. Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Raipur, 492099, Chhattisgarh, India

2. Department of Microbiology, All India Institute of Medical Sciences (AIIMS), Raipur, 492099, Chhattisgarh, India

Abstract

Abstract: Leprosy, often known as Hansen's disease is a contagious chronic infectious disease caused by Mycobacterium leprae (M. leprae). Our methodology is easily repeatable in tertiary care settings with diagnostic accuracy resources and staff capable of building a stewardship team. Comprehensive antimicrobial policies and programmes are required to properly alleviate the initial issue.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery

Reference19 articles.

1. WHO Leprosy ; Available From: 2021

2. Thangaraju P; Velmurugan H; Yella SST; Venkatesan S; vigilance needed in treating leprosy patients in accordance with WHO’s AWaRe Adv Anti-Infect Drug Discov 2022,17(2),95-102

3. National Health Portal Available From 2021 https://www.nhp.gov.in/disease/skin/leprosy

4. Lockwood D.N.J.; Penna G.O.; Lambert S.; Pai V.V.; Walker S.L.; Safer and newer antimicrobial drugs for leprosy – time to test monthly ROM in an adequately powered randomised trial? Lepr Rev 2022,93(2),96-101

5. WHO Guidelines for the diagnosis, treatment and prevention of leprosy Available from: (Accessed: April 8, 2022)2019